# Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention

> **NCT06692140** · NA · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 3150 (estimated)

## Conditions studied

- Ischemia, Myocardial
- Coronary Artery Disease
- Percutaneous Coronary Intervention (PCI)

## Interventions

- **DEVICE:** Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)
- **DEVICE:** PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))

## Key facts

- **NCT ID:** NCT06692140
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-16
- **Primary completion:** 2028-07-01
- **Final completion:** 2032-07-01
- **Target enrollment:** 3150 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06692140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06692140, "Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06692140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*